GR
Galera Therapeutics, Inc.
GRTX · OTC
$17.15 +9.80% (+$1.53)
Market Cap $3.56B
P/E Ratio 23.91x
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
30 /100
Expensive P/E 23.91x
P/B 709.35x
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Rev. growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
21 /100
Poor ROIC 114.16%
ROA 2,417.83%
Asset turnover 0.00x
Debt
100 /100
Low Debt/Equity 0.00x
Current ratio 5.31x
Int. coverage N/A
Stability
4 /100
Unstable Beta 2.61x
EPS volatility 273.83%
Profitable years 1
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about GRTX
Online
Sector
Healthcare
Industry
Biotechnology
CEO
J. Mel Sorensen
Employees
3
Headquarters
Malvern